New Delhi, May 12 (PTI) Sun Pharma Advanced Research Company (SPARC) plans to raise up to Rs 1,200 crore by way of issuing warrants to the company's promoter Dilip Shanghvi and other entities.

The proposal was approved by the company's board during its meeting held on Wednesday, according to a regulatory filing.

As per the filing, the board considered and approved issuing "up to 6,74,70,203 warrants each convertible into, or exchangeable for, one equity share within the period of 18 months at a price of Rs 178 each" to Dilip Shantilal Shanghvi, promoter of the company and to certain other non-promoter group persons.

These warrants -- aggregating up to Rs 12,00,96,96,134 -- would be allotted by way of a preferential issue.

Upon issue of warrants, an amount equivalent to 25 per cent of the total issue size shall be called upfront from the proposed allottees, the filing said.

Shares of SPARC on Wednesday rose 6.14 per cent to close at Rs 239.55 apiece on the BSE. HRS hrs

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)